Kirmani-MW Enfermedades infecciosas 3.ed

4 4 8 | Manual Washington ® de especialidades clínicas. Enfermedades infecciosas 8. Peterson LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA . 2013;310(3): 308-315. doi:10.1001/jama.2013.8042. 9. Staples J, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of an re-emerging infectious disease. Clin Infect Dis . 2009;49(6):942-948. 10. Rodríguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzón S, Sebastian Hurtado-Zapata J. Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and 14. Diallo B, Sissoko D, Loman NJ, et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis . 2016;63(10):1353. [Epub 2016 septiembre 1]. 15. Ebola transmission linked to a single traditional funeral ceremony – Kissidougou, Guinea, diciembre, 2014–enero 2015. Morb Mortal Wkly Rep . 2014;64:386-388. 16. CDC – Ebola Virus Disease (EVD) Information for Clinicians in U.S. Healthcare Settings. https:// www.cdc.gov/vhf/ebola/healthcare-us/preparing/clinicians.html. Acceso 12/1/2017. 17. Henao-Restrepo AM, Longini IM, Egger M et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial. Lancet . 2017;389(10068):505-518. meta-analysis. Arthritis Care Res (Hoboken) . 2016;68(12):1849. 11. Monath TP, Vasconcelos PF. Yellow fever. J Clin Virol . 2015;64. 12. Yellow Fever. https://www.cdc.gov/yellowfever/index.html. Acceso 10/12/2017. 13. CDC: Ebola. https://www.cdc.gov/vhf/ebola/index.html. Acceso 10/12/2017.

SAMPLE